NCT04152031

Brief Summary

The long-term objective of this project is to improve human health and impact health care delivery by developing intelligent technologies that aid with health monitoring and intervention. The immediate objective of this project is to design, evaluate and validate machine learning-based software algorithms that recognize daily activities, provide activity-aware medicine reminder interventions and provide insights on intervention timings that yield successful compliance. The investigators hypothesize that many individuals with needs for medicine intervention can be more compliant with their medicine regimen if prompts are provided at the right times and in the right context. The investigators plan to accomplish these objectives by 1) enhancing and validating software algorithms that recognize daily activities and activity transitions, 2) developing and validating activity-aware medicine prompting interventions for mobile devices, and 3) designing technologies to analyze medicine reminder successes and failures. The proposed work will partner real-time methodologies for validation and algorithmic development with smart phone data, utilize novel activity discovery algorithms, and employ activity recognition and prediction algorithms in the development of activity-aware prompting.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable heart-failure

Timeline
Completed

Started Oct 2016

Typical duration for not_applicable heart-failure

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 20, 2016

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 5, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 5, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 22, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 5, 2019

Completed
Last Updated

April 27, 2023

Status Verified

April 1, 2023

Enrollment Period

2.8 years

First QC Date

October 22, 2019

Last Update Submit

April 25, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Medication adherence rate

    The Russell's adherence score will be used to measure medication adherence rate. A 3-hour window centered on the prescribed dosing time will be considered. A dose taken within this time window will be given a full score for that dosing time; a dose taken outside the window but within a 6 hour window will be given a half score for that dosing time; and missed doses will receive a score of 0. Each participant will be assigned a score from 0.0 to 1.0 for each day. The scores for each subject will be averaged to obtain weekly adherence rates. The overall adherence rate will be computed by taking an average other the entire study period.

    Through study completion, an average of 1 year

Interventions

Participants receive medication reminders on a smartphone. The reminders are generated through machine learning algorithms that automate the process of medication prompting according to successful medication contexts that occurred in the past.

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • have a diagnosis of HF and recently hospitalized for HF exacerbation
  • age ≥ 21 years;
  • live independently (not in an institutional setting); and
  • willing to carry the smartphone throughout the day.

You may not qualify if:

  • any serious co-morbidities (e.g. malignancy, neurological disorder),
  • impaired cognition,
  • inability to understand, read, write, or speak English or Spanish
  • major or uncorrected hearing or vision loss.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart FailureCardiovascular Diseases

Condition Hierarchy (Ancestors)

Heart Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Faculty

Study Record Dates

First Submitted

October 22, 2019

First Posted

November 5, 2019

Study Start

October 20, 2016

Primary Completion

August 5, 2019

Study Completion

August 5, 2019

Last Updated

April 27, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

We do not expect to share the data for this feasibility study. We, however, consider any requests for data access from other investigators. Those requesting the data will provide a data-sharing agreement to protect the participant's privacy and will receive only de-identified data.